07-08-2024 |
AH |
|
AVIR |
Atea Pharmaceuticals, Inc. |
290.57 |
-0.48 |
-0.76 |
-0.34 |
Atea Pharmaceuticals GAAP EPS of -$0.48 beats by $0.29 [8/7/2024 5:35 PM] |
3.47 |
0.20 (6.12%) |
3.27 |
0.0 (0.00%) |
2.77 - 4.60 |
172,410 |
210,000 |
3,346 |
|
|
14-05-2024 |
AH |
|
AVIR |
Atea Pharmaceuticals, Inc. |
327.40 |
-0.75 |
-0.61 |
-0.43 |
Atea Pharmaceuticals GAAP EPS of -$0.75 misses by $0.14 [5/14/2024 4:16 PM] |
3.71 |
-0.25 (-6.44%) |
3.96 |
0.0 (0.00%) |
2.77 - 5.19 |
628,267 |
210,000 |
3,239 |
|
|
28-02-2024 |
AH |
|
AVIR |
Atea Pharmaceuticals |
350.00 |
-0.47 |
-0.44 |
0.00 |
Atea Pharmaceuticals GAAP EPS of -$0.47 beats by $0.03 [2/28/2024 4:28 PM] |
4.32 |
-0.05 (-1.14%) |
4.40 |
0.03 (0.69%) |
2.77 - 5.19 |
481,077 |
380,000 |
10,941 |
|
|
08-11-2023 |
AH |
|
AVIR |
Atea Pharmaceuticals, Inc. |
270.21 |
-0.40 |
-0.46 |
-0.10 |
Atea Pharmaceuticals GAAP EPS of -$0.40 [11/8/2023 4:22 PM] |
3.00 |
-0.29 (-8.97%) |
3.25 |
-0.04 (-1.22%) |
2.85 - 5.32 |
460,465 |
430,000 |
3,513 |
|
|
08-08-2023 |
AH |
|
AVIR |
Atea Pharmaceuticals, Inc. |
289.40 |
-0.34 |
-0.47 |
-0.38 |
Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15 [8/8/2023 5:49 PM] |
3.52 |
0.11 (3.37%) |
3.41 |
0.0 (0.00%) |
2.94 - 9.79 |
313,179 |
250,000 |
3,861 |
|
|
08-05-2023 |
AH |
4:05 PM ET (May 8) |
AVIR |
Atea Pharmaceuticals, Inc. |
277.53 |
-0.43 |
-0.51 |
-0.51 |
Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07 [5/8/2023 4:13 PM] |
3.31 |
-0.09 (-2.65%) |
3.40 |
0.0 (0.00%) |
2.94 - 9.79 |
622,693 |
540,000 |
6,241 |
|
|
28-02-2023 |
AH |
4:05 PM ET (Feb 28) |
AVIR |
Atea Pharmaceuticals, Inc. |
332.32 |
-0.41 |
-0.45 |
1.34 |
Atea Pharmaceuticals GAAP EPS of -$0.41 beats by $0.04 [2/28/2023 4:44 PM] |
3.23 |
-0.31 (-8.62%) |
3.49 |
-0.05 (-1.41%) |
3.22 - 9.79 |
515,795 |
380,000 |
545 |
|
|
07-11-2022 |
AH |
4:05 PM ET (Nov 7) |
AVIR |
Atea Pharmaceuticals, Inc. |
503.71 |
-0.10 |
-0.44 |
-0.34 |
Atea Pharmaceuticals GAAP EPS of -$0.10 beats by $0.34 [11/7/2022 4:10 PM] |
5.30 |
-0.57 (-9.71%) |
6.00 |
0.13 (2.21%) |
5.04 - 11.72 |
985,866 |
470,000 |
10,598 |
|
|
08-08-2022 |
AH |
4:05 PM ET (Aug 8) |
AVIR |
Atea Pharmaceuticals, Inc. |
666.06 |
-0.38 |
-0.52 |
0.02 |
Atea Pharmaceuticals GAAP EPS of -$0.38 beats by $0.14 [8/8/2022 4:37 PM] |
8.48 |
-0.11 (-1.28%) |
8.81 |
0.22 (2.56%) |
5.31 - 46.91 |
782,904 |
330,000 |
644 |
|
|
10-05-2022 |
PM |
0:00 AM ET (May 10) |
AVIR |
Atea Pharmaceuticals, Inc. |
459.58 |
-0.51 |
-0.58 |
0.34 |
Atea Pharmaceuticals GAAP EPS of -$0.51 beats by $0.05 [5/10/2022 6:38 AM] |
5.78 |
0.45 (8.44%) |
5.55 |
0.22 (4.13%) |
5.31 - 46.91 |
927,596 |
825,688 |
15,068 |
|
|
28-02-2022 |
AH |
4:00 PM ET (Feb 28) |
AVIR |
Atea Pharmaceuticals, Inc. |
516.90 |
1.34 |
0.32 |
0.00 |
Atea Pharmaceuticals GAAP EPS of $1.34 beats by $0.96, revenue of $192.2M beats by $81.11M [2/28/2022 4:25 PM] |
6.46 |
0.12 (1.81%) |
6.88 |
0.54 (8.52%) |
5.50 - 79.49 |
2,554,993 |
1,030,000 |
70,016 |
|
|
11-11-2021 |
AH |
4:05 PM ET (Nov 11) |
AVIR |
Atea Pharmaceuticals, Inc. |
903.92 |
-0.34 |
-0.05 |
-1.74 |
Atea Pharmaceuticals EPS misses by $0.17, misses on revenue [11/11/2021 4:39 PM] |
11.34 |
0.70 (6.58%) |
11.10 |
0.46 (4.32%) |
10.28 - 94.17 |
2,493,938 |
1,810,000 |
20,107 |
|
|
12-08-2021 |
AH |
4:05 PM ET (Aug 12) |
AVIR |
Atea Pharmaceuticals, Inc. |
2,720 |
0.02 |
0.01 |
0.00 |
Atea Pharmaceuticals EPS beats by $0.02, beats on revenue [8/12/2021 4:25 PM] |
27.84 |
-3.27 (-10.51%) |
30.60 |
-0.51 (-1.64%) |
18.72 - 94.17 |
1,729,304 |
1,060,000 |
11,421 |
|
|
13-05-2021 |
AH |
7:35 PM ET (May 13) |
AVIR |
Atea Pharmaceuticals, Inc. |
1,710 |
0.34 |
-0.05 |
0.00 |
Atea Pharmaceuticals EPS beats by $0.39, beats on revenue [5/13/2021 4:51 PM] |
22.96 |
3.74 (19.45%) |
20.89 |
1.67 (8.69%) |
18.72 - 94.17 |
1,555,160 |
1,070,000 |
5,463 |
|
|
30-03-2021 |
AH |
7:35 PM ET (Mar 30) |
AVIR |
Atea Pharmaceuticals, Inc. |
4,970 |
N/A |
0.25 |
0.00 |
Atea Pharmaceuticals EPS beats by $0.94 [3/30/2021 5:01 PM] |
61.58 |
5.36 (9.52%) |
56.25 |
0.02 (0.04%) |
24.15 - 94.17 |
444,642 |
380,000 |
850 |
|
|